From: A phase I/II clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced cervical cancer
OAR
Dose constraints for each HBT
Dose constraints for combination of EBRT and all HBTs (EQD2)
Rectum D2cc
<6.15 Gy
< 75 Gy
Bladder D2cc
< 7.30 Gy
< 90 Gy
Sigmoid D2cc
< 6.15 Gy